Antigenicity analysis of different regions of the severe acute respiratory syndrome coronavirus nucleocapsid protein.

Abstract

BACKGROUND The widespread threat of severe acute respiratory syndrome (SARS) to human health has made urgent the development of fast and accurate analytical methods for its early diagnosis and a safe and efficient antiviral vaccine for preventive use. For this purpose, we investigated the antigenicity of different regions of the SARS coronavirus (SARS-CoV) nucleocapsid (N) protein. METHODS The cDNA for full-length N protein and its various regions from the SARS-CoV was cloned and expressed in Escherichia coli. After purification, all of the protein fragments were printed on glass slides to fabricate a protein microarray and then probed with the sera from SARS patients to determine the reactivity of these protein fragments. RESULTS The full-length protein and two other fragments reacted with all 52 sera tested. Four important regions with possible epitopes were identified and named as EP1 (amino acids 51-71), EP2 (134-208), EP3 (249-273), and EP4 (349-422), respectively. EP2 and EP4 possessed linear epitopes, whereas EP1 and EP2 were able to form conformational epitopes that could react with most (>80%) of the tested sera. EP3 and EP4 also formed conformational epitopes, and antibodies against these epitopes existed in all 52 of the sera tested. CONCLUSION The N protein is a highly immunogenic protein of the SARS-CoV. Conformational epitopes are important for this protein, and antigenicity of the COOH terminus is higher than that of the NH(2) terminus. The N protein is a potential diagnostic antigen and vaccine candidate for SARS-CoV.

6 Figures and Tables

Statistics

0204060'05'06'07'08'09'10'11'12'13'14'15'16'17
Citations per Year

68 Citations

Semantic Scholar estimates that this publication has 68 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Chen2004AntigenicityAO, title={Antigenicity analysis of different regions of the severe acute respiratory syndrome coronavirus nucleocapsid protein.}, author={Zeliang Chen and Decui Pei and Lingxiao Jiang and Yajun Song and Jin Wang and Hongxia Wang and Dongsheng Zhou and Junhui Zhai and Zongmin Du and Bei Li and Maofeng Qiu and Yanping Han and Zhaobiao Guo and Ruifu Yang}, journal={Clinical chemistry}, year={2004}, volume={50 6}, pages={988-95} }